Removal of intra-abdominal visceral adipose tissue improves glucose tolerance in rats: Role of hepatic triglyceride storage

Physiology and Behavior

Volumn 104, Issue 5, 2011, Pages 845-854

  Foster, Michelle T ^a   Shi, Haifei ^b   Seeley, Randy J ^a   Woods, Stephen C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MIAMI UNIVERSITY   (United States)

Author keywords

Carnitine palmitoyltransferase; Fat transplantation; Insulin sensitivity; Lipectomy; Lipoprotein lipase

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EPIDIDYMIS FAT; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HEPATIC VEIN; HISTOLOGY; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIPECTOMY; LIPID STORAGE; MALE; MESENTERY; METABOLIC REGULATION; NONHUMAN; OMENTUM; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; TISSUE TRANSPLANTATION; WHITE ADIPOSE TISSUE;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; GENE EXPRESSION REGULATION; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIVER; MALE; RATS; RATS, LONG-EVANS; TRIGLYCERIDES;

EID: 80053051122     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.064     Document Type: Article

References (55)

1. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991, 14:1132-1143.
2. Kissebah A.H., Krakower G.R. Regional adiposity and morbidity. Physiol Rev 1994, 74:761-811.
3. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
4. Bergman R.N. Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein?. Diabetologia 2000, 43:946-952.
5. Williamson J.R., Kreisberg R.A., Felts P.W. Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 1966, 56:247-254.
6. Williamson J.R. Mechanism for the stimulation in vivo of hepatic gluconeogenesis by glucagon. Biochem J 1966, 101:11C-14C.
7. Clarke S.D. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br J Nutr 2000, 83(Suppl 1):S59-S66.
8. Xu J., Nakamura M.T., Cho H.P., Clarke S.D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J Biol Chem 1999, 274:23577-23583.
9. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., Kraegen E.W. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 1997, 46:1768-1774.
10. Ferrannini E., Barrett E.J., Bevilacqua S., DeFronzo R.A. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983, 72:1737-1747.
11. Fabbrini E., Magkos F., Mohammed B.S., Pietka T., Abumrad N.A., Patterson B.W., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009, 106:15430-15435.
12. Kamada Y., Takehara T., Hayashi N. Adipocytokines and liver disease. J Gastroenterol 2008, 43:811-822.
13. Monti L.D., Brambilla P., Stefani I., Caumo A., Magni F., Poma R., et al. Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Diabetologia 1995, 38:739-747.
14. Arner P. Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev 2002, 18(Suppl 2):S5-S9.
15. Thorne A., Lonnqvist F., Apelman J., Hellers G., Arner P. A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 2002, 26:193-199.
16. Fabbrini E., Tamboli R.A., Magkos F., Marks-Shulman P.A., Eckhauser A.W., Richards W.O., et al. Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology 2010, 139:448-455.
17. Herrera M.F., Pantoja J.P., Velazquez-Fernandez D., Cabiedes J., Aguilar-Salinas C., Garcia-Garcia E., et al. Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial. Diabetes Care 2010, 33:1413-1418.
18. Barzilai N., She L., Liu B.Q., Vuguin P., Cohen P., Wang J., et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 1999, 48:94-98.
19. Gabriely I., Ma X.H., Yang X.M., Atzmon G., Rajala M.W., Berg A.H., et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?. Diabetes 2002, 51:2951-2958.
20. Kim Y.W., Kim J.Y., Lee S.K. Surgical removal of visceral fat decreases plasma free fatty acid and increases insulin sensitivity on liver and peripheral tissue in monosodium glutamate (MSG)-obese rats. J Korean Med Sci 1999, 14:539-545.
21. del Mar Romero M., Fernandez-Lopez J.A., Esteve M., Alemany M. Site-related white adipose tissue lipid-handling response to oleoyl-estrone treatment in overweight male rats. Eur J Nutr 2009, 48:291-299.
22. Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Diabetes Res Clin Pract 1994, 24(Suppl):S111-S116.
23. Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Ann N Y Acad Sci 1995, 748:399-406.
24. Harris R.B., Leibel R.L. Location, location, location. Cell Metab 2008, 7:359-361.
25. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996, 20:291-302.
26. Jensen M.D. Health consequences of fat distribution. Horm Res 1997, 48(Suppl 5):88-92.
27. Yu R., Kim C.S., Kwon B.S., Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity (Silver Spring) 2006, 14:1353-1362.
28. Romero Mdel M., Fernandez-Lopez J.A., Esteve M., Alemany M. Different modulation by dietary restriction of adipokine expression in white adipose tissue sites in the rat. Cardiovasc Diabetol 2009, 8:42.
29. Coutard M., Osborne-Pellegrin M. The rat testicular artery: a model of spontaneous aneurysmal-like structure formation. Am J Pathol 1992, 141:1053-1061.
30. Taicher G.Z., Tinsley F.C., Reiderman A., Heiman M.L. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 2003, 377:990-1002.
31. Foster M.T., Bartness T.J. Sympathetic but not sensory denervation stimulates white adipocyte proliferation. Am J Physiol Regul Integr Comp Physiol 2006, 291:R1630-R1637.
32. Shi H., Strader A.D., Sorrell J.E., Chambers J.B., Woods S.C., Seeley R.J. Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis. Am J Physiol Endocrinol Metab 2008, 294:E630-E639.
33. Kim D.H., Sandoval D., Reed J.A., Matter E.K., Tolod E.G., Woods S.C., et al. The role of GM-CSF in adipose tissue inflammation. Am J Physiol Endocrinol Metab 2008, 295:E1038-E1046.
34. Foster M.T., Shi H., Seeley R.J., Woods S.C. Transplantation or removal of intra-abdominal adipose tissue prevents age-induced glucose insensitivity. Physiol Behav 2010, 101:282-288.
35. Fujioka S., Matsuzawa Y., Tokunaga K., Kawamoto T., Kobatake T., Keno Y., et al. Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 1991, 15:853-859.
36. Riches F.M., Watts G.F., Hua J., Stewart G.R., Naoumova R.P., Barrett P.H. Reduction in visceral adipose tissue is associated with improvement in apolipoprotein B-100 metabolism in obese men. J Clin Endocrinol Metab 1999, 84:2854-2861.
37. Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
38. Ayala J.E., Samuel V.T., Morton G.J., Obici S., Croniger C.M., Shulman G.I., et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 2010, 3:525-534.
39. Yost T.J., Rodgers C.M., Eckel R.H. Suction lipectomy: outcome relates to region-specific lipoprotein lipase activity and interval weight change. Plast Reconstr Surg 1993, 92:1101-1108. discussion 9-11.
40. Lambert E.V., Hudson D.A., Bloch C.E., Koeslag J.H. Metabolic response to localized surgical fat removal in nonobese women. Aesthetic Plast Surg 1991, 15:105-110.
41. Mauer M.M., Harris R.B., Bartness T.J. The regulation of total body fat: lessons learned from lipectomy studies. Neurosci Biobehav Rev 2001, 25:15-28.
42. Shi H., Bowers R.R., Bartness T.J. Norepinephrine turnover in brown and white adipose tissue after partial lipectomy. Physiol Behav 2004, 81:535-542.
43. Shi H., Song C.K., Giordano A., Cinti S., Bartness T.J. Sensory or sympathetic white adipose tissue denervation differentially affects depot growth and cellularity. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1028-R1037.
44. Mauer M.M., Bartness T.J. Body fat regulation after partial lipectomy in Siberian hamsters is photoperiod dependent and fat pad specific. Am J Physiol 1994, 266:R870-R878.
45. Jensen M.D. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 2006, 14(Suppl 1):20S-24S.
46. Westerbacka J., Kolak M., Kiviluoto T., Arkkila P., Siren J., Hamsten A., et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007, 56:2759-2765.
47. Dobbins R.L., Szczepaniak L.S., Bentley B., Esser V., Myhill J., McGarry J.D. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 2001, 50:123-130.
48. Konrad D., Rudich A., Schoenle E.J. Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue. Diabetologia 2007, 50:833-839.
49. Hocking S.L., Chisholm D.J., James D.E. Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment. Diabetologia 2008, 51:900-902.
50. Tran T.T., Yamamoto Y., Gesta S., Kahn C.R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008, 7:410-420.
51. Rytka J.M., Wueest S., Schoenle E.J., Konrad D. The portal theory supported by venous drainage-selective fat transplantation. Diabetes 2010, 60:56-63.
52. Matsumoto F., Bujo H., Kuramochi D., Saito K., Shibasaki M., Takahashi K., et al. Effects of nutrition on the cell survival and gene expression of transplanted fat tissues in mice. Biochem Biophys Res Commun 2002, 295:630-635.
53. Langer S., Sinitsina I., Biberthaler P., Krombach F., Messmer K. Revascularization of transplanted adipose tissue: a study in the dorsal skinfold chamber of hamsters. Ann Plast Surg 2002, 48:53-59.
54. Schneider B.S., Faust I.M., Hemmes R., Hirsch J. Effects of altered adipose tissue morphology on plasma insulin levels in the rat. Am J Physiol 1981, 240:E358-E362.
55. Kelley D.E., Thaete F.L., Troost F., Huwe T., Goodpaster B.H. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000, 278:E941-E948.